De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
EC Healthcare Toekomstige groei
Future criteriumcontroles 4/6
EC Healthcare zal naar verwachting groeien in winst en omzet met respectievelijk 97.7% en 11.5% per jaar. De winst per aandeel zal naar verwachting groeien met 97.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.8% zijn.
Belangrijke informatie
97.7%
Groei van de winst
97.6%
Groei van de winst per aandeel
| Consumer Services winstgroei | 21.8% |
| Inkomstengroei | 11.5% |
| Toekomstig rendement op eigen vermogen | 11.8% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 26 Jul 2024 |
Recente toekomstige groei-updates
Recent updates
Little Excitement Around EC Healthcare's (HKG:2138) Revenues As Shares Take 31% Pounding
Sep 05
EC Healthcare (HKG:2138) Might Be Having Difficulty Using Its Capital Effectively
Jul 26EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement
May 13When Should You Buy EC Healthcare (HKG:2138)?
Apr 26Is EC Healthcare (HKG:2138) A Risky Investment?
Feb 07Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch
Dec 24EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005
Dec 08Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital
Dec 01At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?
Sep 15EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042
Aug 24Is EC Healthcare (HKG:2138) Using Too Much Debt?
Aug 10EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042
Jul 14EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042
Jun 26Is There Now An Opportunity In EC Healthcare (HKG:2138)?
Jun 15Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital
May 12Is EC Healthcare (HKG:2138) Potentially Undervalued?
Mar 08EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends
Feb 03EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year
Dec 20Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?
Oct 25EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return
Sep 20EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042
Sep 01EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 28EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042
Jul 14EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042
Jun 26When Should You Buy EC Healthcare (HKG:2138)?
May 26EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around
Apr 18Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?
Feb 24EC Healthcare (HKG:2138) Could Easily Take On More Debt
Feb 11EC Healthcare (HKG:2138) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Dec 26EC Healthcare Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next
Dec 02Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 3/31/2026 | 5,289 | 237 | N/A | 1,170 | 1 |
| 3/31/2025 | 4,806 | 159 | N/A | 990 | 2 |
| 3/31/2024 | 4,211 | -19 | 528 | 689 | N/A |
| 12/31/2023 | 4,157 | -11 | 422 | 709 | N/A |
| 9/30/2023 | 4,104 | -4 | 317 | 729 | N/A |
| 6/30/2023 | 3,989 | 33 | 255 | 667 | N/A |
| 3/31/2023 | 3,875 | 70 | 193 | 605 | N/A |
| 12/31/2022 | 3,622 | 93 | 162 | 499 | N/A |
| 9/30/2022 | 3,369 | 117 | 132 | 392 | N/A |
| 6/30/2022 | 3,144 | 157 | 240 | 500 | N/A |
| 3/31/2022 | 2,920 | 198 | 348 | 608 | N/A |
| 12/31/2021 | 2,823 | 253 | 479 | 684 | N/A |
| 9/30/2021 | 2,727 | 309 | 610 | 760 | N/A |
| 6/30/2021 | 2,404 | 251 | 541 | 690 | N/A |
| 3/31/2021 | 2,080 | 193 | 472 | 621 | N/A |
| 12/31/2020 | 1,854 | 163 | 487 | 597 | N/A |
| 9/30/2020 | 1,627 | 133 | 503 | 573 | N/A |
| 6/30/2020 | 1,788 | 210 | 505 | 574 | N/A |
| 3/31/2020 | 1,949 | 287 | 507 | 576 | N/A |
| 12/31/2019 | 2,023 | 325 | 273 | 452 | N/A |
| 9/30/2019 | 2,098 | 364 | 40 | 327 | N/A |
| 6/30/2019 | 1,975 | 363 | -5 | 283 | N/A |
| 3/31/2019 | 1,852 | 361 | -49 | 238 | N/A |
| 12/31/2018 | 1,715 | 355 | 108 | 278 | N/A |
| 9/30/2018 | 1,578 | 348 | 265 | 317 | N/A |
| 6/30/2018 | 1,450 | 314 | 269 | 320 | N/A |
| 3/31/2018 | 1,322 | 279 | 272 | 324 | N/A |
| 12/31/2017 | 1,253 | 266 | N/A | 302 | N/A |
| 9/30/2017 | 1,183 | 253 | N/A | 280 | N/A |
| 6/30/2017 | 1,079 | 227 | N/A | 230 | N/A |
| 3/31/2017 | 975 | 201 | N/A | 180 | N/A |
| 12/31/2016 | 878 | 170 | N/A | 123 | N/A |
| 9/30/2016 | 780 | 139 | N/A | 66 | N/A |
| 6/30/2016 | 744 | 144 | N/A | 71 | N/A |
| 3/31/2016 | 708 | 149 | N/A | 76 | N/A |
| 12/31/2015 | 688 | 166 | N/A | 105 | N/A |
| 9/30/2015 | 668 | 183 | N/A | 134 | N/A |
| 6/30/2015 | 645 | 179 | N/A | 146 | N/A |
| 3/31/2015 | 621 | 174 | N/A | 159 | N/A |
| 3/31/2014 | 490 | 81 | N/A | 145 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er wordt voorspeld dat 2138 de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 2.3% ).
Winst versus markt: Er wordt verwacht dat 2138 de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.
Hoge groeiwinsten: Er wordt verwacht dat 2138 binnen 3 jaar winstgevend zal worden.
Omzet versus markt: De omzet van 2138 ( 11.5% per jaar) zal naar verwachting sneller groeien dan de markt Hong Kong ( 7.3% per jaar).
Hoge groei-inkomsten: De omzet van 2138 ( 11.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 2138 zal naar verwachting over 3 jaar laag zijn ( 11.8 %).